{
    "Trade/Device Name(s)": [
        "BreathID\u00ae Smart System",
        "BreathID Hp Lab System"
    ],
    "Submitter Information": "Meridian Bioscience Israel Ltd.",
    "510(k) Number": "K223185",
    "Predicate Device Reference 510(k) Number(s)": [
        "K220494"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "MSQ",
        "JJQ"
    ],
    "Summary Letter Date": "October 6, 2022",
    "Summary Letter Received Date": "October 12, 2022",
    "Submission Date": "October 2, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter Fetus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Helicobacter pylori",
        "13CO2/12CO2 ratio"
    ],
    "Specimen Type(s)": [
        "Exhaled breath"
    ],
    "Specimen Container(s)": [
        "Breath sample bags"
    ],
    "Instrument(s)/Platform(s)": [
        "BreathID\u00ae Smart System device",
        "Auto Sampler"
    ],
    "Method(s)/Technology(ies)": [
        "Molecular Correlation Spectroscopy (MCS)",
        "Infrared spectrometry"
    ],
    "Methodologies": [
        "Breath test",
        "Optical absorbance measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Kit",
        "Device",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for modified BreathID\u00ae Smart System for noninvasive detection and monitoring of Helicobacter pylori infection via 13C-urea breath testing using MCS technology",
    "Indications for Use Summary": "Intended for noninvasive measurement of exhaled 13CO2/12CO2 ratio as an aid in initial diagnosis and post-treatment monitoring of Helicobacter pylori infection in adults and children ages 3-17, to be administered by trained personnel on order of a healthcare practitioner",
    "fda_folder": "Microbiology"
}